<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
    <channel>
        <title><![CDATA[Avalon Pernell - Journalist]]></title>
        <description><![CDATA[Avalon Pernell is an equities reporter for Bloomberg News in New York focused on biotech and health-care companies. She previously worked in Berlin as a Fulbright Young Journalist awardee.]]></description>
        <link>https://www.bloomberg.com/authors/AWWN9PkT9uE/avalon-pernell</link>
        <generator>RSS for Node</generator>
        <lastBuildDate>Sat, 09 May 2026 12:40:14 GMT</lastBuildDate>
        <atom:link href="https://www.bloomberg.com/authors/AWWN9PkT9uE/avalon-pernell.rss" rel="self" type="application/rss+xml"/>
        <copyright><![CDATA[Copyright 2026 BLOOMBERG L.P. ALL RIGHTS RESERVED]]></copyright>
        <language><![CDATA[en]]></language>
        <item>
            <title><![CDATA[Health Firms Odyssey, Mobia Fall After $454 Million IPO Haul]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-05-08/odyssey-therapeutics-climbs-11-after-304-million-us-ipo</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-05-08/odyssey-therapeutics-climbs-11-after-304-million-us-ipo</guid>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Fri, 08 May 2026 15:58:48 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iTMKE1bNJyPk/v1/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iTMKE1bNJyPk/v1/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>Odyssey Therapeutics Inc. signage during the company&apos;s IPO at the Nasdaq MarketSite in New York.</media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Immune System Biotech Odyssey Seeks $238.3 Million in US IPO]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-05-04/immune-system-biotech-odyssey-seeks-238-3-million-in-us-ipo</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-05-04/immune-system-biotech-odyssey-seeks-238-3-million-in-us-ipo</guid>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Mon, 04 May 2026 10:45:13 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[Psychiatry Drugmaker Seaport Rises 10% After Trading Debut]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-05-01/drugmaker-seaport-climbs-17-after-255-million-upsized-us-ipo</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-05-01/drugmaker-seaport-climbs-17-after-255-million-upsized-us-ipo</guid>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Fri, 01 May 2026 16:43:48 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[Antidepressant Maker Seaport Raises $255 Million in Upsized IPO]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-05-01/antidepressant-maker-seaport-raises-255-million-in-upsized-ipo</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-05-01/antidepressant-maker-seaport-raises-255-million-in-upsized-ipo</guid>
            <category><![CDATA[world]]></category>
            <dc:creator><![CDATA[Anthony Hughes]]></dc:creator>
            <pubDate>Fri, 01 May 2026 01:57:59 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[Novo-Backed Drugmaker Avalyn Soars 64% After Trading Debut]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-04-30/novo-backed-drugmaker-avalyn-soars-44-after-300-million-us-ipo</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-04-30/novo-backed-drugmaker-avalyn-soars-44-after-300-million-us-ipo</guid>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Thu, 30 Apr 2026 16:36:02 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ifpGMAF29M.A/v1/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ifpGMAF29M.A/v1/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>Lyn Baranowski, chief executive officer of Avalyn Pharma Inc., center, rings the opening bell during the company&apos;s initial public offering (IPO) at the Nasdaq MarketSite in New York, US, on Thursday, April 30, 2026. Avalyn Pharma Inc., a biopharma company developing inhaled treatments for rare lung diseases, raised million in a US initial public offering that priced at the top of its marketed range.</media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Novo-Backed Drugmaker Avalyn Raises $300 Million in Upsized IPO]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-04-30/novo-backed-drugmaker-avalyn-raises-300-million-in-upsized-ipo</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-04-30/novo-backed-drugmaker-avalyn-raises-300-million-in-upsized-ipo</guid>
            <category><![CDATA[world]]></category>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Thu, 30 Apr 2026 01:12:27 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[Cancer Drug Developer Erasca Sinks by Record 55% After Patient Death]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-04-28/cancer-drug-developer-erasca-sinks-by-record-55-after-patient-death</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-04-28/cancer-drug-developer-erasca-sinks-by-record-55-after-patient-death</guid>
            <category><![CDATA[markets]]></category>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Tue, 28 Apr 2026 17:23:43 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[Psychiatry Drugmaker Seaport Seeks $212.4 Million in US IPO]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-04-27/antidepressant-drugmaker-seaport-seeks-212-4-million-in-us-ipo</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-04-27/antidepressant-drugmaker-seaport-seeks-212-4-million-in-us-ipo</guid>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Mon, 27 Apr 2026 10:32:14 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[Obesity Drugmaker Kailera Soars 63% After $625 Million IPO]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-04-17/obesity-firm-kailera-therapeutics-up-63-after-625-million-ipo</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-04-17/obesity-firm-kailera-therapeutics-up-63-after-625-million-ipo</guid>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Fri, 17 Apr 2026 17:41:57 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iCOseKUx4NmY/v1/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iCOseKUx4NmY/v1/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>The New York Stock Exchange.</media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Obesity Treatment Firm Kailera Upsizes IPO to Raise $625 Million]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-04-16/obesity-treatment-firm-kailera-upsizes-ipo-to-raise-625-million</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-04-16/obesity-treatment-firm-kailera-upsizes-ipo-to-raise-625-million</guid>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Thu, 16 Apr 2026 23:44:10 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[UnitedHealth’s Last Bear Stands Pat After Medicare Rate Hike]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-04-10/unitedhealth-s-last-bear-stands-pat-after-medicare-rate-hike</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-04-10/unitedhealth-s-last-bear-stands-pat-after-medicare-rate-hike</guid>
            <category><![CDATA[markets]]></category>
            <dc:creator><![CDATA[Angel Adegbesan]]></dc:creator>
            <pubDate>Fri, 10 Apr 2026 11:00:01 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iNbaxUuDeucA/v1/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iNbaxUuDeucA/v1/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>UnitedHealth Group Inc. signage on the floor at the New York Stock Exchange (NYSE) in New York.</media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Medtronic Unit MiniMed Shares Fall 8% After $560 Million IPO]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-03-06/medtronic-diabetes-unit-minimed-falls-2-after-560-million-ipo</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-03-06/medtronic-diabetes-unit-minimed-falls-2-after-560-million-ipo</guid>
            <category><![CDATA[markets]]></category>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Fri, 06 Mar 2026 17:21:47 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[Medtronic Unit Raises $560 Million in US IPO Priced Below Range]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-03-06/medtronic-unit-raises-560-million-in-us-ipo-priced-below-range</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-03-06/medtronic-unit-raises-560-million-in-us-ipo-priced-below-range</guid>
            <category><![CDATA[markets]]></category>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Fri, 06 Mar 2026 00:38:01 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[Medtronic Diabetes Unit MiniMed’s IPO Sparks Analyst Debate]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-03-04/medtronic-diabetes-unit-minimed-s-ipo-sparks-analyst-debate</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-03-04/medtronic-diabetes-unit-minimed-s-ipo-sparks-analyst-debate</guid>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Wed, 04 Mar 2026 18:12:00 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i1Om6uQt9EyY/v1/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i1Om6uQt9EyY/v1/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>The New York Stock Exchange (NYSE) in New York, US, on Monday, March 2, 2026. US stocks fluctuated, bouncing back from earlier losses though still remaining in negative territory as traders debated the potential market impact from an escalating conflict in the Middle East that triggered a spike in oil prices.</media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Medtronic Diabetes Unit MiniMed Seeks $784 Million in US IPO]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-02-24/medtronic-diabetes-business-minimed-seeks-784-million-in-us-ipo</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-02-24/medtronic-diabetes-business-minimed-seeks-784-million-in-us-ipo</guid>
            <category><![CDATA[markets]]></category>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Tue, 24 Feb 2026 13:09:52 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[Hims & Hers Shorts Up $1.3 Billion This Year on Legal Risk]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-02-13/hims-hers-shorts-up-1-3-billion-this-year-on-legal-risk</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-02-13/hims-hers-shorts-up-1-3-billion-this-year-on-legal-risk</guid>
            <category><![CDATA[markets]]></category>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Fri, 13 Feb 2026 16:05:54 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[Former Karaoke Company Drags Logistics Into the ‘AI Scare Trade’]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-02-12/logistics-stocks-plunge-as-latest-victim-in-ai-disruption-trade</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-02-12/logistics-stocks-plunge-as-latest-victim-in-ai-disruption-trade</guid>
            <category><![CDATA[technology]]></category>
            <dc:creator><![CDATA[Joel Leon]]></dc:creator>
            <pubDate>Thu, 12 Feb 2026 16:55:25 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/imJSm6DrZ6Jw/v3/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/imJSm6DrZ6Jw/v3/-1x-1.jpg"/>
                <media:description></media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Eye Care Firm SpyGlass Pharma Soars 65% In Trading Debut]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-02-06/eye-care-firm-spyglass-pharma-soars-50-after-150-million-ipo</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-02-06/eye-care-firm-spyglass-pharma-soars-50-after-150-million-ipo</guid>
            <category><![CDATA[markets]]></category>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Fri, 06 Feb 2026 17:23:55 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iGOvA1LaaUrQ/v1/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iGOvA1LaaUrQ/v1/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>Traders work on the floor the New York Stock Exchange.</media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Hair Restoration Firm Veradermics Jumps 122% In Trading Debut]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-02-04/hair-loss-firm-veradermics-jumps-124-after-256-million-ipo</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-02-04/hair-loss-firm-veradermics-jumps-124-after-256-million-ipo</guid>
            <category><![CDATA[markets]]></category>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Wed, 04 Feb 2026 18:49:02 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[Hair Loss Biopharma Firm Veradermics Raises $256 Million in IPO]]></title>
            <link>https://www.bloomberg.com/news/articles/2026-02-04/hair-loss-biopharma-firm-veradermics-raises-256-million-in-ipo</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2026-02-04/hair-loss-biopharma-firm-veradermics-raises-256-million-in-ipo</guid>
            <category><![CDATA[markets]]></category>
            <dc:creator><![CDATA[Avalon Pernell]]></dc:creator>
            <pubDate>Wed, 04 Feb 2026 03:19:10 GMT</pubDate>
        </item>
    </channel>
</rss>